EMILY REED: Open Payments
NPI 1942255740 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,820 in 101 payments from 17 companies in 2025. Trend: 2023 $1,398 · 2024 $1,280 · 2025 $1,820
Food & beverage: $1,820
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $321 |
| ABBVIE INC. | 15 | $261 |
| Novo Nordisk Inc | 16 | $225 |
| PFIZER INC. | 12 | $200 |
| Axsome Therapeutics, Inc. | 3 | $151 |
| GlaxoSmithKline, LLC. | 12 | $142 |
| Lilly USA, LLC | 8 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Exact Sciences Corporation | 4 | $73 |
| Antares Pharma, Inc. | 3 | $56 |
Products named: AIRSUPRA, LINZESS, Symbravo, MOUNJARO, NURTEC ODT, Ozempic, TRELEGY ELLIPTA, REXULTI.
Industry payments across OK — which companies pay providers there.
